Terumo Cardiovascular, a global leader in medical devices for cardiac and vascular surgery, and a division of Japan-based Terumo, has opened a new $42m manufacturing facility in La Lima, Cartago, Costa Rica.

The plant will produce the company’s complete line of custom perfusion circuits for customers worldwide. Terumo is the first company to produce this line of medical equipment in the country.

Approximately 300 staff will be employed at the 14,585m2 facility by the end of 2022. In its first phase, the plant will primarily serve customers in the Americas and Australia. A second phase of operation will launch in early 2023 to supply customers in Europe, the Middle East and Africa.

In a press release, Robert DeRyke, president of Terumo Cardiovascular, explained why Costa Rica was selected for the new facility: “Costa Rica has a strong cultural alignment with Terumo Cardiovascular and the countries where we operate. Its economic and political stability, and strong commitment to sustainability, is an ecosystem-strengthening draw for numerous service and medical device manufacturers that tap into their highly skilled talent. This opening enhances our global competitiveness and helps us grow based on strategic investments.”